Sep 13, 2022 / 04:20PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Hologic this afternoon, and we have Karleen Oberton, CFO; and Ryan Simon from Investor Relations, representing the company.
Before we get started, just need to rattle off the disclosure statement here. Please see the Morgan Stanley disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo with that, guys, thanks for doing this. Maybe Karleen, just to set the stage, can you talk about sort of some of your key accomplishments over the last 12 months? And what are you looking forward to as you head into fiscal '23?
Karleen M. Oberton - Hologic, Inc. - CFO
Sure. Well, thank you, Tejas, and thanks for having us. We're excited to be
Trustpilot
